Clearside Biomedical, Inc. (CLSD) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Hatteras Venture Advisors IV SBIC, LLC mit 2,080,364 Aktien. Weitere bedeutende Anteilseigner sind Cormorant Asset Management, LLC und Hatteras Venture Advisors III, LLC.
CLSD Insider-Beteiligungen
Größter Aktionär
Hatteras Venture Advisors IV SBIC, LLC
2,080,364 Aktien
Käufe (12 Monate)
0
$0.00 Wert
Verkäufe (12 Monate)
0
$0.00 Wert
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Hatteras Venture Advisors Iv Sbic, Llc |
10 Percent Owner |
2,080,364 |
2017-01-19 |
|
| 2 |
Cormorant Asset Management, Llc |
10 Percent Owner |
1,988,208 |
2016-06-13 |
|
| 3 |
Hatteras Venture Advisors Iii, Llc |
10 Percent Owner |
1,774,654 |
2017-01-19 |
|
| 4 |
Lasezkay George M |
CEO |
500,000 |
2025-01-10 |
|
| 5 |
Whitmore Bradford T |
10 Percent Owner |
444,444 |
2024-02-09 |
|
| 6 |
Ciulla Thomas |
Chief Medical Officer |
291,890 |
2023-01-20 |
|
| 7 |
Chong Ngai Hang Victor |
Chief Medical Officer |
250,000 |
2025-01-10 |
|
| 8 |
Deignan Charles A. |
Chief Financial Officer |
200,000 |
2025-01-10 |
|
| 9 |
White Daniel H. |
President and CEO |
200,000 |
2019-02-07 |
|
| 10 |
Thorp Clay |
Director |
176,141 |
2025-02-24 |
|
| 11 |
Noronha Glenn |
Chief Scientific Officer |
96,000 |
2017-12-12 |
|
| 12 |
Raymond Brion S. |
Chief Commercial Officer |
50,000 |
2019-06-04 |
|
| 13 |
Humphries William D. |
Director |
45,000 |
2024-06-21 |
|
| 14 |
Gibney Anthony S |
Director |
45,000 |
2024-06-21 |
|
| 15 |
Shaffer Christy L |
Director |
45,000 |
2024-06-21 |
|
| 16 |
Croarkin Richard |
Director |
45,000 |
2024-06-21 |
|
| 17 |
Edwards Jeffrey L |
Director |
45,000 |
2024-06-21 |
|
| 18 |
Hutson Nancy J |
Director |
45,000 |
2024-06-21 |
|
| 19 |
Yerxa Benjamin R |
Director |
45,000 |
2024-06-21 |
|
| 20 |
Zaytsev Evgeny |
Director |
11,250 |
2018-06-21 |
|
Keine Beteiligungsdaten für CLSD verfügbar.
